These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16103435)

  • 1. Design options for molecular epidemiology research within cohort studies.
    Rundle AG; Vineis P; Ahsan H
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1899-907. PubMed ID: 16103435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study designs for biobank-based epidemiologic research on chronic diseases.
    Läärä E
    Methods Mol Biol; 2011; 675():165-78. PubMed ID: 20949387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nested case-control studies.
    Ernster VL
    Prev Med; 1994 Sep; 23(5):587-90. PubMed ID: 7845919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic issues in the design and interpretation of studies on metabolic polymorphisms and cancer.
    Vineis P; Malats N
    IARC Sci Publ; 1999; (148):51-61. PubMed ID: 10493248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Logistics and design issues in the use of biological samples in observational epidemiology.
    Potter JD
    IARC Sci Publ; 1997; (142):31-7. PubMed ID: 9354909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of cohort sampling designs: some surprising results.
    Langholz B; Thomas DC
    Biometrics; 1991 Dec; 47(4):1563-71. PubMed ID: 1786329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
    Wang MH; Shugart YY; Cole SR; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):706-11. PubMed ID: 19258478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in the design of molecular and genetic epidemiologic studies.
    Fowke JH
    J Prev Med Public Health; 2009 Nov; 42(6):343-8. PubMed ID: 20009479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External comparisons from nested case-control designs.
    Suissa S; Edwardes MD; Boivin JF
    Epidemiology; 1998 Jan; 9(1):72-8. PubMed ID: 9430272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure.
    Cologne JB; Sharp GB; Neriishi K; Verkasalo PK; Land CE; Nakachi K
    Int J Epidemiol; 2004 Jun; 33(3):485-92. PubMed ID: 15105408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis.
    Tworoger SS; Hankinson SE
    Cancer Causes Control; 2006 Sep; 17(7):889-99. PubMed ID: 16841256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4).
    Guiguet M; Mary-Krause M; Ename B; Costagliola D; Grabar S
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):468-74. PubMed ID: 18324608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research.
    Schneeweiss S; Stürmer T; Maclure M
    Pharmacoepidemiol Drug Saf; 1997 Oct; 6 Suppl 3():S51-9. PubMed ID: 15073755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating interaction between genetic and environmental risk factors: efficiency of sampling designs within a cohort.
    Bureau A; Diallo MS; Ordovas JM; Cupples LA
    Epidemiology; 2008 Jan; 19(1):83-93. PubMed ID: 18091418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining data from 2 nested case-control studies of overlapping cohorts to improve efficiency.
    Salim A; Hultman C; Sparén P; Reilly M
    Biostatistics; 2009 Jan; 10(1):70-9. PubMed ID: 18550564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designs for synthetic case-control studies in open cohorts.
    Robins JM; Prentice RL; Blevins D
    Biometrics; 1989 Dec; 45(4):1103-16. PubMed ID: 2611319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of internal dose: chemical agents.
    Coggon D; Friesen MD
    IARC Sci Publ; 1997; (142):95-101. PubMed ID: 9354914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimax two-stage-designs with applications to tissue banking case-control studies.
    Shuster J; Link M; Camitta B; Pullen J; Behm F
    Stat Med; 2002 Sep; 21(17):2479-93. PubMed ID: 12205694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.